S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
How major US stock indexes fared Friday, 2/23/2024
MarketBeat Week in Review – 2/19 - 2/23
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Closing prices for crude oil, gold and other commodities
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
Mike Tyson’s Wisdom: Life, Planning, and Resilience
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
How major US stock indexes fared Friday, 2/23/2024
MarketBeat Week in Review – 2/19 - 2/23
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Closing prices for crude oil, gold and other commodities
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
Mike Tyson’s Wisdom: Life, Planning, and Resilience
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
How major US stock indexes fared Friday, 2/23/2024
MarketBeat Week in Review – 2/19 - 2/23
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Closing prices for crude oil, gold and other commodities
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
Mike Tyson’s Wisdom: Life, Planning, and Resilience
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
How major US stock indexes fared Friday, 2/23/2024
MarketBeat Week in Review – 2/19 - 2/23
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Closing prices for crude oil, gold and other commodities
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
Mike Tyson’s Wisdom: Life, Planning, and Resilience

Ligand Pharmaceuticals (LGND) Earnings Date, Estimates & Call Transcripts

$75.87
+2.31 (+3.14%)
(As of 02/23/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

LGND Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LGND Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ligand Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241$0.75$0.75$0.75 
Q2 20241$0.67$0.67$0.67 
Q3 20241$0.80$0.80$0.80 
Q4 20241$0.75$0.75$0.75 
FY 20244$2.97$2.97$2.97 
Q1 20251$0.82$0.82$0.82 
Q2 20251$0.85$0.85$0.85 
Q3 20251$0.88$0.88$0.88 

LGND Earnings Date and Information

Ligand Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Tuesday, February 27th, 2024. Ligand Pharmaceuticals will be holding an earnings conference call on Tuesday, February 27th at 8:30 AM Eastern. Interested parties can register for or listen to the call..

Ligand Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/27/2024
Confirmed)
-------  
11/8/2023Q3 2023$0.68$1.02+$0.34$2.16$27.22 million$32.87 million    
8/8/2023Q2 2023$0.76$1.42+$0.66$2.07$24.74 million$26.37 million    
5/4/2023Q1 2023$0.89$2.28+$1.39$1.59$33.55 million$43.98 million    
2/22/2023Q4 2022$1.23$1.36+$0.13$0.52$39.63 million$50.40 million    
11/7/2022Q3 2022$0.09($0.20)($0.29)($0.42)$38.47 million$66.09 million
8/8/2022Q2 2022$0.12($0.14)($0.26)($0.23)$39.70 million$57.42 million
5/4/2022Q1 2022$0.19$0.15($0.04)$1.21$34.21 million$45.70 million      
2/17/2022Q4 2021$0.97$1.34+$0.37$2.98$62.70 million$72.47 million    
11/9/2021Q3 2021$0.61$1.58+$0.97$1.56$60.46 million$64.84 million    
7/29/2021Q2 2021$1.15$1.63+$0.48$0.53$73.32 million$84.68 million    
5/2/2021Q1 2021$1.13$1.41+$0.28$1.01$63.00 million$55.10 million  












Ligand Pharmaceuticals Earnings - Frequently Asked Questions

When is Ligand Pharmaceuticals's earnings date?

Ligand Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Tuesday, February 27th, 2024. Learn more on LGND's earnings history.

How much revenue does Ligand Pharmaceuticals generate each year?

Ligand Pharmaceuticals (NASDAQ:LGND) has a recorded annual revenue of $196.24 million.

How much profit does Ligand Pharmaceuticals generate each year?

Ligand Pharmaceuticals (NASDAQ:LGND) has a recorded net income of -$33.36 million. LGND has generated $0.68 earnings per share over the last four quarters.

What is Ligand Pharmaceuticals's price-to-earnings ratio?

Ligand Pharmaceuticals (NASDAQ:LGND) has a trailing price-to-earnings ratio of 111.58 and a forward price-to-earnings ratio of 18.37.

What is Ligand Pharmaceuticals's EPS forecast for next year?

Ligand Pharmaceuticals's earnings are expected to decrease from $4.13 per share to $2.91 per share in the next year, which is a -29.54% change.


More Earnings Resources from MarketBeat

This page (NASDAQ:LGND) was last updated on 2/24/2024 by MarketBeat.com Staff